Experimental Traumatic Brain Injury during Adolescence Enhances Cocaine Rewarding Efficacy and Dysregulates Dopamine and Neuroimmune Systems in Brain Reward Substrates.
addiction
adolescent
behavior
neuroinflammation
traumatic brain injury
Journal
Journal of neurotrauma
ISSN: 1557-9042
Titre abrégé: J Neurotrauma
Pays: United States
ID NLM: 8811626
Informations de publication
Date de publication:
01 01 2020
01 01 2020
Historique:
pubmed:
28
7
2019
medline:
13
4
2021
entrez:
27
7
2019
Statut:
ppublish
Résumé
Although clinical studies identify traumatic brain injury (TBI) as a risk factor for the development of substance use disorder, much remains unknown about the possible underlying pathogenesis and age-specific effects. Thus, the aim of this study is to test the hypothesis that at an age of ongoing maturation, adolescent TBI alters elements of the reward pathway, resulting in increased sensitivity to the rewarding effects of a subthreshold dose of cocaine that does not induce significant behavioral changes in naïve, non-injured mice. Specifically, these results were derived from the combination of the controlled cortical impact model of TBI, performed on either adolescent (6 weeks) or young adult (8 weeks) mice, followed by the cocaine-induced conditioned place preference assay 2 weeks later. Using three-dimensional isosurface rendering and volumetric image analysis, TBI was found to induce neuromorphological changes such as decreased dendritic complexity and reduced spine density in brain regions essential for reward perception and processing of drug-induced euphoria. Further, we demonstrated that these neuronal changes may affect the differential expression of dopamine-associated genes. Our analysis also provided evidence for age-related differences in immune response and the distinct involvement of augmented microglial phagocytic activity in the remodeling of neuronal structures in the adolescent TBI brain. Our studies suggest that TBI during adolescence, a period associated with ongoing maturation of dopaminergic systems, may subsequently enhance the abuse liability of cocaine in adulthood.
Identifiants
pubmed: 31347447
doi: 10.1089/neu.2019.6472
pmc: PMC6921296
doi:
Substances chimiques
Dopamine
VTD58H1Z2X
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
27-42Subventions
Organisme : NIDA NIH HHS
ID : P30 DA013429
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA046833
Pays : United States
Organisme : NIDA NIH HHS
ID : T32 DA007237
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS086570
Pays : United States
Références
J Neurotrauma. 2017 Apr 1;34(7):1364-1381
pubmed: 27784203
Arthritis Res Ther. 2010;12(3):R90
pubmed: 20478071
Front Pharmacol. 2012 Feb 28;3:27
pubmed: 22403545
Brain Behav Immun. 2017 May;62:30-34
pubmed: 27575003
PLoS One. 2015 Apr 24;10(4):e0125130
pubmed: 25910266
Neuroreport. 2001 Aug 8;12(11):2323-7
pubmed: 11496104
J Neurosci. 2012 Nov 14;32(46):16223-32
pubmed: 23152606
Brain Res Bull. 2016 Jun;124:214-21
pubmed: 27210290
Neurology. 2008 Mar 18;70(12):948-55
pubmed: 18347317
J Neurosci. 2014 Aug 6;34(32):10511-27
pubmed: 25100586
J Neurotrauma. 2017 Jan 1;34(1):165-181
pubmed: 27026056
J Addict Med. 2007 Mar;1(1):33-9
pubmed: 21768930
J Head Trauma Rehabil. 2009 Sep-Oct;24(5):324-32
pubmed: 19858966
Science. 2011 Sep 9;333(6048):1456-8
pubmed: 21778362
J Neurosurg. 2007 Oct;107(4):844-53
pubmed: 17937233
Behav Brain Res. 2015 Feb 15;279:22-30
pubmed: 25446758
Arch Phys Med Rehabil. 2013 Oct;94(10):1940-50
pubmed: 23770276
Brain Inj. 2008 Mar;22(3):223-31
pubmed: 18297594
Trends Neurosci. 2013 Apr;36(4):209-17
pubmed: 23260014
Eur J Pharmacol. 2006 Nov 21;550(1-3):95-106
pubmed: 17011546
Oncotarget. 2018 Jan 13;9(11):10016-10028
pubmed: 29515787
Psychiatr Q. 2019 Mar;90(1):151-158
pubmed: 30465326
Drug Alcohol Depend. 2015 Apr 1;149:145-50
pubmed: 25683823
BMJ Open. 2016 Nov 10;6(11):e011824
pubmed: 28186929
Pharmacol Biochem Behav. 2009 Mar;92(1):131-4
pubmed: 19032962
J Neurochem. 2005 Oct;95(2):457-65
pubmed: 16190869
Front Neuroanat. 2014 Oct 02;8:110
pubmed: 25324733
PLoS Pathog. 2011 Nov;7(11):e1002374
pubmed: 22102816
Behav Pharmacol. 2017 Aug;28(5):405-407
pubmed: 28125509
Front Immunol. 2016 Dec 05;7:556
pubmed: 27994591
Eur J Nucl Med. 2000 Sep;27(9):1410-4
pubmed: 11007526
Neurotherapeutics. 2010 Oct;7(4):366-77
pubmed: 20880501
Neuroscience. 2017 Apr 21;348:180-190
pubmed: 28196657
Proc Natl Acad Sci U S A. 1988 Jul;85(14):5274-8
pubmed: 2899326
Eur J Neurosci. 2019 Aug;50(3):2134-2145
pubmed: 30118561
J Neurosurg. 2012 Jun;116(6):1368-78
pubmed: 22462511
Nat Neurosci. 2011 Mar;14(3):285-93
pubmed: 21346746
Brain Res. 1991 Mar 15;543(2):227-35
pubmed: 1905576
Brain Inj. 2012;26(2):139-50
pubmed: 22360520
Behav Brain Res. 2009 Mar 2;198(1):45-50
pubmed: 18996417
Nature. 2004 Jun 17;429(6993):761-6
pubmed: 15190253
Nat Neurosci. 2005 Nov;8(11):1445-9
pubmed: 16251986
J Int Neuropsychol Soc. 2008 Mar;14(2):233-42
pubmed: 18282321
J Neurosci. 2011 Jun 8;31(23):8381-94
pubmed: 21653843
J Neurosci Methods. 1991 Oct;39(3):253-62
pubmed: 1787745
Science. 2016 Aug 19;353(6301):783-5
pubmed: 27540166
Nat Neurosci. 2006 Aug;9(8):1050-6
pubmed: 16829955
J Head Trauma Rehabil. 2006 Sep-Oct;21(5):375-8
pubmed: 16983222
Brain Res. 1988 Jul 26;456(2):317-23
pubmed: 3208083
Psychol Med. 2018 Mar;48(4):679-691
pubmed: 28780927
Sci Rep. 2018 Jul 2;8(1):9941
pubmed: 29967344
Brain Behav Immun. 2010 Oct;24(7):1190-201
pubmed: 20570721
J Neurotrauma. 2014 Oct 15;31(20):1700-10
pubmed: 24934382
Curr Opin Neurobiol. 2013 Aug;23(4):559-63
pubmed: 23628232
Psychopharmacology (Berl). 2017 Jun;234(11):1671-1681
pubmed: 28251297
Acta Neuropathol. 2002 Jun;103(6):541-9
pubmed: 12012085
J Neurotrauma. 2019 Apr 1;36(7):1040-1053
pubmed: 30259790
Cell Transplant. 2017 Jul;26(7):1178-1192
pubmed: 28933216
Am J Addict. 2015 Jun;24(4):341-7
pubmed: 25662909
JAMA Psychiatry. 2017 May 1;74(5):511-519
pubmed: 28297025
Curr Opin Behav Sci. 2015 Oct 1;5:108-115
pubmed: 26665151
Neuroimage. 2010 Feb 1;49(3):2536-43
pubmed: 19913102
Nat Rev Neurosci. 2013 Feb;14(2):128-42
pubmed: 23329160
J Neurochem. 1979 Jul;33(1):89-95
pubmed: 458474
Psychopharmacology (Berl). 2010 Jun;210(2):121-35
pubmed: 20352414
Nat Rev Neurosci. 2014 Apr;15(4):209-16
pubmed: 24646669
J Head Trauma Rehabil. 2015 May-Jun;30(3):185-97
pubmed: 25955705
J Neurosci. 2017 Nov 8;37(45):10855-10866
pubmed: 29118215
Brain Res. 2007 Feb 23;1134(1):171-9
pubmed: 17196177
Neurosci Biobehav Rev. 2017 Jun;77:209-218
pubmed: 28359860
Nat Neurosci. 2014 Mar;17(3):400-6
pubmed: 24487234
Brain Behav Immun. 2018 Jan;67:299-307
pubmed: 28911981
Neuroscience. 2009 Oct 6;163(2):540-51
pubmed: 19555742
Am J Psychiatry. 2005 Aug;162(8):1403-13
pubmed: 16055761
J Neurotrauma. 2016 May 1;33(9):895-903
pubmed: 26153729
Neuropsychopharmacology. 2010 Jan;35(1):147-68
pubmed: 19794405
J Neurosci. 2004 Feb 18;24(7):1551-60
pubmed: 14973230
MMWR Surveill Summ. 2017 Mar 17;66(9):1-16
pubmed: 28301451